Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users

H. Thiede, M. Romero, K. Bordelon, Holly Hagan, C. Murrill

Research output: Contribution to journalArticle

Abstract

Routine monitoring of human immunodeficiency virus (HIV) and risk behaviors among injection drug users (IDUs) is difficult outside drug treatment settings. We developed and implemented a survey of recently arrested IDUs to describe the prevalence of HIV, drug use, and sexual behaviors among them. A probability sampling survey was instituted in the King County Correctional Facility in Seattle, Washington; to sample recently arrested IDUs at the time of booking and in the jail health clinic between 1998 and 1999. Following HIV risk assessment and blood draw, additional information on drug use practices was gathered using a standardized questionnaire. Potential participants who were released from jail early could complete the study at a nearby research storefront office. Of the 4,344 persons intercepted at booking, 503 (12%) reported injection drug use, and 201 of the IDUs (40%) participated in the study. An additional 161 IDUs were enrolled in the study from the jail health clinic. Among the 348 unduplicated subjects, HIV prevalence was 2%; in the past 6 months, 69% reported two or more shooting partners, 72% used a cooker after someone else, 60% shared a syringe to divide up drugs, and 62% injected with used needles. Only 37% reported being hepatitis C seropositive, and 8% reported hepatitis B vaccination. It was feasible to conduct a jail-based survey of recently arrested IDUs that yielded useful information. The high prevalence of reported risky drug use practices warrants ongoing monitoring and illustrates the need for improving prevention programs for HIV and hepatitis B and C in this population, including expansion of hepatitis C screening and provision of hepatitis B vaccination at the jail health clinic.

Original languageEnglish (US)
Pages (from-to)264-278
Number of pages15
JournalJournal of Urban Health
Volume78
Issue number2
DOIs
StatePublished - 2001

Fingerprint

Risk-Taking
Drug Users
risk behavior
HIV
drug
Injections
contagious disease
Hepatitis C
drug use
Hepatitis B
Pharmaceutical Preparations
vaccination
Health
Vaccination
health
monitoring
Syringes
Surveys and Questionnaires
Sexual Behavior
Needles

Keywords

  • Correctional Facility
  • Hepatitis B and C Prevention
  • HIV
  • Injection Drug Users
  • Risk Behaviors

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users. / Thiede, H.; Romero, M.; Bordelon, K.; Hagan, Holly; Murrill, C.

In: Journal of Urban Health, Vol. 78, No. 2, 2001, p. 264-278.

Research output: Contribution to journalArticle

Thiede, H. ; Romero, M. ; Bordelon, K. ; Hagan, Holly ; Murrill, C. / Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users. In: Journal of Urban Health. 2001 ; Vol. 78, No. 2. pp. 264-278.
@article{e07b8e5145054e01b1ed4313e9b78a92,
title = "Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users",
abstract = "Routine monitoring of human immunodeficiency virus (HIV) and risk behaviors among injection drug users (IDUs) is difficult outside drug treatment settings. We developed and implemented a survey of recently arrested IDUs to describe the prevalence of HIV, drug use, and sexual behaviors among them. A probability sampling survey was instituted in the King County Correctional Facility in Seattle, Washington; to sample recently arrested IDUs at the time of booking and in the jail health clinic between 1998 and 1999. Following HIV risk assessment and blood draw, additional information on drug use practices was gathered using a standardized questionnaire. Potential participants who were released from jail early could complete the study at a nearby research storefront office. Of the 4,344 persons intercepted at booking, 503 (12{\%}) reported injection drug use, and 201 of the IDUs (40{\%}) participated in the study. An additional 161 IDUs were enrolled in the study from the jail health clinic. Among the 348 unduplicated subjects, HIV prevalence was 2{\%}; in the past 6 months, 69{\%} reported two or more shooting partners, 72{\%} used a cooker after someone else, 60{\%} shared a syringe to divide up drugs, and 62{\%} injected with used needles. Only 37{\%} reported being hepatitis C seropositive, and 8{\%} reported hepatitis B vaccination. It was feasible to conduct a jail-based survey of recently arrested IDUs that yielded useful information. The high prevalence of reported risky drug use practices warrants ongoing monitoring and illustrates the need for improving prevention programs for HIV and hepatitis B and C in this population, including expansion of hepatitis C screening and provision of hepatitis B vaccination at the jail health clinic.",
keywords = "Correctional Facility, Hepatitis B and C Prevention, HIV, Injection Drug Users, Risk Behaviors",
author = "H. Thiede and M. Romero and K. Bordelon and Holly Hagan and C. Murrill",
year = "2001",
doi = "10.1093/jurban/78.2.264",
language = "English (US)",
volume = "78",
pages = "264--278",
journal = "Journal of Urban Health",
issn = "1099-3460",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "2",

}

TY - JOUR

T1 - Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users

AU - Thiede, H.

AU - Romero, M.

AU - Bordelon, K.

AU - Hagan, Holly

AU - Murrill, C.

PY - 2001

Y1 - 2001

N2 - Routine monitoring of human immunodeficiency virus (HIV) and risk behaviors among injection drug users (IDUs) is difficult outside drug treatment settings. We developed and implemented a survey of recently arrested IDUs to describe the prevalence of HIV, drug use, and sexual behaviors among them. A probability sampling survey was instituted in the King County Correctional Facility in Seattle, Washington; to sample recently arrested IDUs at the time of booking and in the jail health clinic between 1998 and 1999. Following HIV risk assessment and blood draw, additional information on drug use practices was gathered using a standardized questionnaire. Potential participants who were released from jail early could complete the study at a nearby research storefront office. Of the 4,344 persons intercepted at booking, 503 (12%) reported injection drug use, and 201 of the IDUs (40%) participated in the study. An additional 161 IDUs were enrolled in the study from the jail health clinic. Among the 348 unduplicated subjects, HIV prevalence was 2%; in the past 6 months, 69% reported two or more shooting partners, 72% used a cooker after someone else, 60% shared a syringe to divide up drugs, and 62% injected with used needles. Only 37% reported being hepatitis C seropositive, and 8% reported hepatitis B vaccination. It was feasible to conduct a jail-based survey of recently arrested IDUs that yielded useful information. The high prevalence of reported risky drug use practices warrants ongoing monitoring and illustrates the need for improving prevention programs for HIV and hepatitis B and C in this population, including expansion of hepatitis C screening and provision of hepatitis B vaccination at the jail health clinic.

AB - Routine monitoring of human immunodeficiency virus (HIV) and risk behaviors among injection drug users (IDUs) is difficult outside drug treatment settings. We developed and implemented a survey of recently arrested IDUs to describe the prevalence of HIV, drug use, and sexual behaviors among them. A probability sampling survey was instituted in the King County Correctional Facility in Seattle, Washington; to sample recently arrested IDUs at the time of booking and in the jail health clinic between 1998 and 1999. Following HIV risk assessment and blood draw, additional information on drug use practices was gathered using a standardized questionnaire. Potential participants who were released from jail early could complete the study at a nearby research storefront office. Of the 4,344 persons intercepted at booking, 503 (12%) reported injection drug use, and 201 of the IDUs (40%) participated in the study. An additional 161 IDUs were enrolled in the study from the jail health clinic. Among the 348 unduplicated subjects, HIV prevalence was 2%; in the past 6 months, 69% reported two or more shooting partners, 72% used a cooker after someone else, 60% shared a syringe to divide up drugs, and 62% injected with used needles. Only 37% reported being hepatitis C seropositive, and 8% reported hepatitis B vaccination. It was feasible to conduct a jail-based survey of recently arrested IDUs that yielded useful information. The high prevalence of reported risky drug use practices warrants ongoing monitoring and illustrates the need for improving prevention programs for HIV and hepatitis B and C in this population, including expansion of hepatitis C screening and provision of hepatitis B vaccination at the jail health clinic.

KW - Correctional Facility

KW - Hepatitis B and C Prevention

KW - HIV

KW - Injection Drug Users

KW - Risk Behaviors

UR - http://www.scopus.com/inward/record.url?scp=0034971686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034971686&partnerID=8YFLogxK

U2 - 10.1093/jurban/78.2.264

DO - 10.1093/jurban/78.2.264

M3 - Article

C2 - 11419580

AN - SCOPUS:0034971686

VL - 78

SP - 264

EP - 278

JO - Journal of Urban Health

JF - Journal of Urban Health

SN - 1099-3460

IS - 2

ER -